Tempest Therapeutics, Inc. (TPST) Operating income 2016–2025
Tempest Therapeutics, Inc. (TPST) annual operating income history from SEC filings — each fiscal year as reported.
-$26.6MFY2025 · since FY2016: -$81.0M → -$26.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.6M | +36.8% |
| FY2024 | -$42.0M | -44.1% |
| FY2023 | -$29.2M | +15.8% |
| FY2022 | -$34.6M | -28.4% |
| FY2021 | -$27.0M | -39.8% |
| FY2020 | -$19.3M | +57.5% |
| FY2019 | -$45.4M | -68.9% |
| FY2018 | -$26.9M | +68.1% |
| FY2017 | -$84.3M | -4.1% |
| FY2016 | -$81.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice